[1]方年富,何庆霞,杨卫生,等.胃蛋白酶原与胃泌素-17在胃癌前病变筛查中的价值[J].医学信息,2019,32(22):170-171.[doi:10.3969/j.issn.1006-1959.2019.22.060]
　FANG Nian-fu,HE Qing-xia,YANG Wei-sheng,et al.The Value of Pepsinogen and Gastrin-17 in the Screening of Gastric Precancerous Lesions[J].Journal of Medical Information,2019,32(22):170-171.[doi:10.3969/j.issn.1006-1959.2019.22.060]
点击复制

胃蛋白酶原与胃泌素-17在胃癌前病变筛查中的价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年22期
页码:
170-171
栏目:
诊疗技术
出版日期:
2019-11-15

文章信息/Info

Title:
The Value of Pepsinogen and Gastrin-17 in the Screening of Gastric Precancerous Lesions
文章编号:
1006-1959（2019）22-0170-02
作者:
方年富; 何庆霞; 杨卫生; 贾克红; 袁光勇; 余恕玉
（江西省景德镇市第二人民医院消化内科，江西 景德镇 333000）
Author(s):
FANG Nian-fu; HE Qing-xia; YANG Wei-sheng; JIA Ke-hong; YUAN Guang-yong; YU Shu-yu
(Department of Gastroenterology,the Second People's Hospital of Jingdezhen,Jingdezhen 333000,Jiangxi,China)
关键词:
胃癌; 胃蛋白酶原; 胃泌素-17; 癌前病变
Keywords:
Gastric cancer; Pepsinogen; Gastrin-17; Precancerous lesions
分类号:
R735.2
DOI:
10.3969/j.issn.1006-1959.2019.22.060
文献标志码:
A
摘要:
目的 探讨血清胃蛋白酶原Ⅰ、Ⅱ（PGⅠ、Ⅱ）与胃泌素-17（G-17）在胃癌前病变中的诊断价值。方法 回顾性分析2018年1月~10月我院收治的消化道患者98例，根据胃镜检查及病理结果分为胃溃疡组32例、萎缩性胃炎组21例、肠上皮化生组25例、低级别上皮内瘤变组20例，另选取同期我院检查的健康体检者30名作为对照组。应用ELISA法检测比较五组血清PGⅠ、PGⅡ、胃蛋白酶原比值PGR，（PGI/PGⅡ）、G-17水平。结果 与对照组比较，胃溃疡组PGⅠ、PGⅡ、G-17升高[（131.83±24.62）μg/L vs（95.29±23.47）μg/L]、[（15.31±6.65）μg/L vs（10.93±2.35）μg/L]、[（15.34±4.22）pmol/L vs（9.31±2.48）pmol/L]，萎缩性胃炎组、肠上皮化生组、低级别上皮内瘤变组PGⅠ、PGR降低，差异有统计学意义（P＜0.05）。结论 血清PGⅠ、PGR、G-17可作为胃癌及其癌前病变筛查的指标。
Abstract:
Objective To investigate the diagnostic value of serum pepsinogen Ⅰ, Ⅱ (PGⅠ, Ⅱ) and gastrin-17 (G-17) in precancerous lesions. Methods A retrospective analysis of 98 patients with digestive tract admitted to our hospital from January to October 2018 was performed. According to the results of gastroscopy and pathology, there were 32 patients with gastric ulcer, 21 patients with atrophic gastritis, and 25 patients with intestinal metaplasia. Twenty patients with low-grade intraepithelial neoplasia were enrolled, and 30 healthy subjects examined in our hospital were selected as the control group. Five groups of serum PGⅠ, PGⅡ pepsin ratio PGR, (PGⅠ/PGⅡ) and G-17 levels were compared by ELISA. Results Compared with the control group, PGⅠ, PGⅡ, and G-17 were elevated in the gastric ulcer group [(131.83±24.62) μg/L vs (95.29±23.47) μg/L], [(15.31±6.65) μg/L vs (10.93± 2.35) μg/L], [(15.34±4.22) pmol/L vs (9.31±2.48) pmol/L], PGⅠ and PGR were decreased in atrophic gastritis group, intestinal metaplasia group and low-grade intraepithelial neoplasia group,the difference was statistically significant (P<0.05). Conclusion Serum PGⅠ, PGⅡ and G-17 can be used as indicators for screening gastric cancer and its precancerous lesions.

参考文献/References:

[1]马英睿,左赞,郭强.血清胃功能检测对萎缩性胃炎诊断及胃癌风险评估的研究进展[J].昆明医科大学学报,2018,39(8):124-128. [2]中华消化杂志编委会.消化性溃疡诊断与治疗规范(2016年,西安)[J].中华消化杂志,2016,36(8):508-513. [3]中华医学会病理分会消化病理学组筹备组.慢性胃炎及上皮性肿瘤胃黏膜活检病理诊断共识[J].中华病理学杂志,2017,46(5):289-293. [4]Al-Rawashdeh O,Ismail ZB,Talafha A,et al.Changes of hematological and biochemical parameters and levels of pepsinogen, histamine and prostaglandins in dairy cows affected with left displacement of the abomasum[J].Pol J Vet Sci,2017,20(1):13-18. [5]陈春春,罗和生,成镀,等.血清胃蛋白酶原在慢性胃部病变中变化的临床研究[J].胃肠病学和肝病学杂志,2018,27(11):1265-1269． [6]陈莫耶,徐倩,孙丽萍,等.血清胃泌素17水平与胃癌及癌前疾病的相关性研究[J].胃肠病学和肝病学杂志,2015,24(2):161-165.

相似文献/References:

[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
　YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(22):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
　RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Journal of Medical Information,2018,31(22):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
　DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Journal of Medical Information,2018,31(22):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
　PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Journal of Medical Information,2018,31(22):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]茅溢恒.幽门螺杆菌抗体、胃泌素17、胃蛋白酶原等联合检测 在体检人群胃疾病筛查中的意义[J].医学信息,2018,31(11):22.[doi:10.3969/j.issn.1006-1959.2018.11.007]
　MAO Yi-heng.The Significance of Combined Detection of Helicobacter Pylori Antibody,Gastrin 17, Pepsinogen,etc.in Gastric Disease Screening in Physical Examination Population[J].Journal of Medical Information,2018,31(22):22.[doi:10.3969/j.issn.1006-1959.2018.11.007]
[6]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
　LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Journal of Medical Information,2022,35(22):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[7]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(22):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[8]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
　LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Journal of Medical Information,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[9]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
　MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Journal of Medical Information,2018,31(22):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[10]潮子健,汪文生,谢宏伟.年龄对胃部常见良性疾病患者的胃蛋白酶原及胃泌素-17水平的影响[J].医学信息,2018,31(23):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
　CHAO Zi-jian,WANG Wen-sheng,XIE Hong-wei.Effect of Age on Pepsinogen and Gastrin-17 Levels in Patients with Common Benign Diseases of the Stomach[J].Journal of Medical Information,2018,31(22):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
[11]谈春晓.胃泌素17和胃蛋白酶原血清学联合检测对胃癌高危人群筛查的临床价值[J].医学信息,2020,33(24):71.[doi:10.3969/j.issn.1006-1959.2020.24.020]
　TAN Chun-xiao.The Clinical Value of the Combined Detection of Gastrin 17 and Pepsinogen Serology in Screening High-risk Groups of Gastric Cancer[J].Journal of Medical Information,2020,33(22):71.[doi:10.3969/j.issn.1006-1959.2020.24.020]
[12]敖先伟,陈小银,孔繁静,等.荆州地区回族与汉族胃癌及胃溃疡患者血液胃蛋白酶原水平比较[J].医学信息,2024,37(03):57.[doi:10.3969/j.issn.1006-1959.2024.03.010]
　AO Xian-wei,CHEN Xiao-yin,KONG Fan-jing,et al.Comparative of Serum Pepsinogen in Hui and Han Nationalities Patients with Gastric Cancer and Gastric Ulcer in Jingzhou Area[J].Journal of Medical Information,2024,37(22):57.[doi:10.3969/j.issn.1006-1959.2024.03.010]

更新日期/Last Update: 2019-11-15